Blog
RSS FeedPosted by Michael Wonder on 13 Aug 2020
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
13 August 2020 - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect ...
Posted by Michael Wonder on 13 Aug 2020
TG Therapeutics announces FDA acceptance of new drug application for umbralisib as a treatment for patients with previously treated marginal zone lymphoma and follicular lymphoma
13 August 2020 - TG Therapeutics today announced that the U.S. FDA has accepted the Company’s new drug application for umbralisib, ...
Posted by Michael Wonder on 13 Aug 2020
Novartis announces FDA filing acceptance of Xolair (omalizumab) pre-filled syringe for self-administration across all indications
13 August 2020 - If approved, Xolair self-administration would offer a more flexible option to help select patients manage their treatment ...
Posted by Michael Wonder on 13 Aug 2020
Elusys Therapeutics receives Health Canada approval for Anthim for the treatment of inhalation anthrax
12 August 2020 - Elusys Therapeutics today announced that Health Canada has approved the company's new drug submission for Anthim ...
Posted by Michael Wonder on 13 Aug 2020
Seattle Genetics announces Tukysa (tucatinib) approved within months for all countries participating in FDA’s Project Orbis initiative
12 August 2020 - Australia joins U.S., Switzerland, Canada and Singapore in approval of Tukysa for the treatment of patients with ...
Posted by Michael Wonder on 13 Aug 2020
TGA approves new gene therapy from Novartis
13 August 2020 - Luxturna has been for the treatment of patients with inherited retinal dystrophy caused by pathological biallelic RPE65 ...
Posted by Michael Wonder on 12 Aug 2020
Australian scientists say too early to pick COVID-19 vaccine race winner in advice to Federal Government
13 August 2020 - The leading group of scientists advising the Federal Government says there is still no clear frontrunner in ...
Posted by Michael Wonder on 12 Aug 2020
US hoses down Russian vaccine, says it will have millions of doses ready year's end
12 August 2020 - US Health Secretary Alex Azar has criticised a COVID-19 vaccine being promoted by Russian President Vladimir ...
Posted by Michael Wonder on 12 Aug 2020
FDA accepts evinacumab biologics license application for priority review as a treatment for patients with HoFH, an ultra-rare inherited form of high cholesterol
12 August 2020 - Homozygous familial hypercholesterolaemia affects approximately 1,300 patients in the U.S., the vast majority of whom are unable ...
Posted by Michael Wonder on 12 Aug 2020
Moderna announces supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19 (mRNA-1273)
11 August 2020 - New U.S. government award up to $1.525 billion for 100 million doses. ...
Posted by Michael Wonder on 12 Aug 2020
Theranexus and BBDF obtain orphan drug designation and rare paediatric disease designation from the FDA for BBDF-101 for Batten disease
11 August 2020 - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases, and Beyond Batten Disease Foundation ...
Posted by Michael Wonder on 12 Aug 2020
Health Canada approves Opdivo (nivolumab) plus Yervoy (ipilimumab) combined with limited chemotherapy for the treatment of metastatic non-small cell lung cancer
11 August 2020 - CheckMate-9LA trial results demonstrated superior overall survival versus chemotherapy, regardless of PD-L1 expression or tumour histology. ...
Posted by Michael Wonder on 11 Aug 2020
Australia pins hopes on potential Oxford University COVID-19 vaccine
11 August 2020 - The Federal Government is positioning itself to secure and manufacture a COVID-19 vaccine in Australia, if ...
Posted by Michael Wonder on 11 Aug 2020
Local doctor may have breakthrough coronavirus cure
11 August 2020 - Local doctor Thomas Borody has found what may be a cheap and easy treatment for COVID-19 patients ...
Posted by Michael Wonder on 11 Aug 2020
Trump’s call for essential drugs to be made in US threatens innovation, says trade group
11 August 2020 - The trade group for the US pharmaceutical industry has warned that President Donald Trump’s latest executive ...